Dusa pharmaceuticals inc (DUSA)
Income statement / Quarterly
Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Product revenues

9,740

11,726

13,420

15,269

9,373

9,671

10,981

8,015

8,700

Cost of product revenues

1,508

1,778

2,069

2,408

1,412

1,471

1,630

1,627

1,782

GROSS MARGIN

8,231

9,948

11,350

12,861

7,961

8,200

9,351

6,387

6,918

Research and development

1,697

2,206

2,050

1,535

1,307

1,108

1,323

1,283

1,250

Marketing and sales

3,353

4,000

4,633

4,768

3,352

3,288

3,973

2,792

3,137

General and administrative

2,906

2,874

3,082

2,635

2,318

2,550

2,452

2,208

2,247

TOTAL OPERATING COSTS

7,958

9,082

9,767

8,938

6,978

6,947

7,749

6,285

6,635

INCOME FROM OPERATIONS

273

865

1,583

3,922

983

1,252

1,601

102

283

Other income

7

1

2

1

9

19

16

61

61

(Loss) gain on change in fair value of warrants

-1,702

1,317

-1,923

-517

2,569

-875

-2,188

-130

-157

(LOSS) INCOME FROM CONTINUING OPERATIONS

-1,421

2,184

-337

3,405

3,561

396

-570

-

-

(LOSS) INCOME FROM DISCONTINUED OPERATIONS

-

-

0

-98

-54

714

-33

-

-

NET (LOSS) INCOME

-1,421

2,184

-337

3,307

3,506

1,110

-604

32

188

CONTINUING OPERATIONS

-0.06

0.09

-

-

0.14

0.02

-

-

-

DISCONTINUED OPERATIONS

-

-

-

-

-

0.03

-

-

-

BASIC NET (LOSS) INCOME PER SHARE

-0.06

0.09

-

-

0.14

0.05

-

0.00

0.01

CONTINUING OPERATIONS

-0.06

0.08

-

-

0.13

0.01

-

-

-

DISCONTINUED OPERATIONS

-

-

-

-

-

0.03

-

-

-

DILUTED NET (LOSS) INCOME PER SHARE

-0.06

0.08

-

-

0.13

0.04

-

0.00

0.01

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, BASIC

25,009

24,951

-

-

24,649

24,539

-

24,209

24,187

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, DILUTED

25,009

26,914

-

-

26,442

26,813

-

24,658

24,566

CONTINUING OPERATIONS

-

-

-0.01

-

-

-

-0.02

-

-

DISCONTINUED OPERATIONS

-

-

0.00

-

-

-

0.00

-

-

NET LOSS PER SHARE

-

-

-0.01

-

-

-

-0.02

-

-